RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

DNA Funded vs Funded Trading Plus

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

DNAF

DNA Funded

FTTP

Funded Trading Plus

EST. 2021

DNA FUNDED

METRIC

FUNDED TRADING PLUS

0/100—

TRUST SCORE

BETTER60/100

0/5—

RATING

BETTER3.5/5

—

PROFIT SPLIT

80%

—

MAX FUNDING

$100,000

—

MIN COST

$1,759

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

DNA FUNDED DETAILS

STEPS: -phase

FUNDED TRADING PLUS DETAILS

STEPS: 2-phase
DRAWDOWN: Fixed
MARKETS: Crypto, Energy, Indices, Metals, Other Commodities, FX
PLATFORMS: cTrader, DXTrade, Match Trader, MT5

DNA Funded PROS

+No performance data is available to identify any above-average metrics for this firm
+No fee, payout, or structure data provided to evaluate competitiveness
+No platform or market data available to assess trading flexibility
+Country of operation (Australia) is noted, but no regulatory or structural data exists

DNA Funded CONS

−No data is provided for this firm, making any meaningful comparison impossible
−Traders cannot assess profit split, funding, or costs against the 84.7% and $186.7 averages
−Complete absence of data is a significant transparency concern for traders making financial decisions

Funded Trading Plus PROS

+On-demand payouts offer faster access to profits than monthly or bi-weekly schedules
+Weekend holding, news trading, and EA use are all permitted
+Four platforms supported (cTrader, DXTrade, Match Trader, MT5) offering broad trader choice
+Wide market access including Crypto, Energy, Indices, Metals, Commodities, and FX

Funded Trading Plus CONS

−Min challenge cost of $1,759 is dramatically above the industry average of $186.7
−Max funding of $100,000 is well below the industry average of $839,272.7
−Profit split of 80% is below the industry average of 84.7%

PROPDNA VERDICT

DNA Funded

Lower trust score (0/100). Slower payouts at —d.

START WITH DNAF